Navigation Links
IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers
Date:9/14/2010

OXNARD, Calif., Sept. 14 /PRNewswire/ -- The launch of IntriMed Technologies and the opening of IntriMed's first state-of-the-industry Innovation Center in Oxnard, Calif. were announced today by IntriPlex Technologies, a global leader in the design and manufacture of ultra-precise components for the data storage and healthcare industries. Founded on a 23 year heritage of engineering innovation, IntriMed (www.intrimed.com) focuses exclusively on delivering outsourcing solutions to the medical device manufacturing industry, and delivers on three value pillars - ongoing innovation, deep collaboration, and engineering and operational excellence.

As with any industry, the medical device industry continues to evolve and adapt to ever-changing market dynamics. Faced with healthcare reform, a new medical device tax, rapid technology advancement and more stringent U.S. Food and Drug Administration (FDA) oversight, original equipment manufacturers (OEMs) are increasingly looking towards strategic, long-term outsourcing partnerships as a means to temper these changes and achieve their revenue, cost and competitive objectives more rapidly.

Leveraging design innovation and manufacturing excellence that has resulted in 44 product and process patents and over 9 billion precision components, IntriMed is well-positioned to help medical device OEMs address these challenges. IntriMed provides deep engineering expertise to support product development from initial concept through volume production and assembly, and taps into OEM objectives to create highly-specialized design and process solutions that result in reduced costs, faster times to market, decreased failure rates and competitive differentiation.

IntriMed's new Innovation Center will support the company's full range of services, including product design and development, rapid prototyping, advanced tooling, precision manufacturing, secondary processing and cleaning, custom metrology and final assembly.

"Medical device manufacturers are adjusting to a 'new normal' of doing more with less," said Larry J. Czapla, IntriMed's president, "but for us this is pretty familiar ground. We've managed to help manufacturers in the disk drive industry save millions of dollars and stay ahead of a huge technology curve by laying the foundation for manufacturing success early on. From the outset, we work closely with the development team to create a tailored approach to design and manufacturing, and to help them achieve new levels of quality, technology and cost-effectiveness."

IntriMed's team of executives holds extensive leadership experience at the world's top medical device companies. The executive team includes Larry J. Czapla, President; Lawney Falloon, Chief Executive Officer; Damon Brink, Ph.D., Chief Technology Officer and Vice President, Engineering; Larry Ellis, Chief Financial Officer; Andrew Lux, Ph.D., Senior Vice President, Operations and Manufacturing; and Howard R. Baker, Vice President, Business Development and Commercial Operations.

For more information about IntriMed Technologies, please visit www.intrimed.com.

About IntriMed TechnologiesIntriMed Technologies designs, manufactures and assembles ultra-precision mechanical components critical to medical device functionality. We draw on more than 23 years of experience helping manufacturers do more with less – providing innovative product and process design, meticulous quality systems, and highly scalable, fully compliant manufacturing capabilities. The result is truly differentiated medical devices produced more cost effectively.

Think "embedded engineering": leveraging our considerable resources so our customers can better focus theirs. To learn more, visit intrimed.com.Media Contact: Priya DuaPorter Novelli Life SciencesPriya.Dua@porternovelli.com323-762-2407
'/>"/>

SOURCE IntriMed Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg based clinical ... Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads to a ... in a group of 20 patients carrying 11778, 14484 and 3460 mutations and having ...
(Date:4/27/2017)... ... April 27, 2017 , ... Sierra Instruments ... on capillary thermal mass flow technology provide exponentially more accurate mass flow data ... 80% of all industrial processes—such as those involving chemical reactions, combustion, respiration, pharmaceutical, ...
(Date:4/27/2017)... NASHVILLE, Tenn. , April 27, 2017  Pendant ... company developing innovative surface modification and drug delivery technologies, ... & Johnson Innovation, JLABS @ Toronto ... Chief Executive Officer of Pendant Biosciences, noted, "We are ... Toronto community, and are honored to ...
(Date:4/26/2017)... Alto, CA, USA (PRWEB) , ... April 26, ... ... popular seminar on FDA’s GMP expectations for phase I clinical trials comes to ... attended by various biotechnology and pharma professionals representing FDA regulated organizations such as ...
Breaking Biology Technology:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
Breaking Biology News(10 mins):